Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of
Related Experiment Video
Updated: Mar 2, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
E F E Wenstedt1, C J Huysentruyt, C J A M Konings
1Department of Internal Medicine, Catharina Hospital Eindhoven, Eindhoven, the Netherlands.
Abstract:
In contrast with uraemic calciphylaxis in end-stage renal disease, causes of and risk factors for non-uraemic calciphylaxis are relatively unknown to clinicians and have yet to become fully established. This report describes a case of non-uraemic calciphylaxis, in which the use of acenocoumarol might have been a risk factor. It is important to raise awareness about this association among clinicians, as vitamin K antagonists have to be stopped for an optimal treatment of this severe condition.
More Related Videos
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Atherosclerosis III: Management